Cart summary

You have no items in your shopping cart.

SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11]

SKU: orb1274601

Description

SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11]

Images & Validation

Tested ApplicationsFC, NeA
ReactivityVirus
Application Notes
Functional Assay: This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2. Can be paired with other antibody for detection in sandwich ELISA format.

Key Properties

Antibody TypePrimary Antibody
HostRabbit
ClonalityRecombinant
IsotypeIgG1k
Clone No.C-A11
Immunogenrecombinant protein (RBD)
TargetS
PurificationProtein A
ConjugationUnconjugated

Storage & Handling

StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Form/AppearanceLiquid
Buffer/Preservatives1X PBS
Concentrationbatch dependent
DisclaimerFor research use only

Alternative Names

Spike protein S1, Spike protein S2, RBD domain, Binding to ACE-2 receptor, SARS-CoV-2 variants, U.K variant B.1.1.7, South Africa variant B.1.351
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11]

Flow cytometry neutralizing assay: C-A11 displayed dose dependent blocking of spike proteins (wild type and UK variant) to ACE2 expressing cells.

SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11]

Affinity assessment of SARS-CoV-2 C-A11 IgG to wild type and B.1.1.7 (UK) S1+S2 trimers. C-A11 possesses very low (pM) KD affinity to both variants.

SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11]

Flow cytomery neutralizing assay of C-A11 (plotted graphs): ACE2 transfected cells were incubated with biotinylated spike protein (0.5 ug/mL) in the presence or absence of antibody. Binding of spike protein was detected with DyLight488 conjugated StreptAvidin. C-A11 efficiently blocked the binding of wild type and UK variant (B.1.1.7) to ACE2 expressing HEK293 cells.

SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11]

Binding of C-A11 to SARS-CoV-2 variants (UK and South Africa): C-A11 shows good cross reactivity to both variants B.1.1.7 (UK) and B.1.351 (S. Africa).

UniProt Details

No UniProt data available

NCBI Reference Sequences

Associated Accession Numbers
Curated reference sequences for the gene transcript and protein product
RefSeqP0DTC2

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

FC
Flow Cytometry
View Protocol

SARS-CoV-2 (COVID-19) Spike RBD Neutralizing Antibody [C-A11] (orb1274601)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Available Sizes

Select a size below

200 μl
$ 1,120.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry